Hello COPIERS and FOLLOWERS.
Today we'll be cashing in some profits in $MITK (Mitek Systems Inc) and buying into the biotech company $STOK.
Recently, $STOK (Stoke Therapeutics Inc) announced pricing of upsized $125 Million public offering. It is a strong BUY, averaging 22 and a high of 35.
🚀This coupled with shares nearly doubled in value Tuesday morning, after the biotechnology company disclosed updated trial data Monday evening for an experimental drug Dravet it’s developing for a form of genetic epilepsy.
Great news for patients and investors too !
Have a great day.
Mike... Show More
